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Abstract
Background: WHO recommends prompt diagnosis and quinine plus clindamycin for treatment of uncomplicated malaria in
the first trimester and artemisinin-based combination therapies in subsequent trimesters. We undertook a systematic review
of women’s access to and healthcare provider adherence to WHO case management policy for malaria in pregnant women.
Methods and Findings: We searched the Malaria in Pregnancy Library, the Global Health Database, and the International
Network for the Rational Use of Drugs Bibliography from 1 January 2006 to 3 April 2014, without language restriction. Data
were appraised for quality and content. Frequencies of women’s and healthcare providers’ practices were explored using
narrative synthesis and random effect meta-analysis. Barriers to women’s access and providers’ adherence to policy were
explored by content analysis using NVivo. Determinants of women’s access and providers’ case management practices were
extracted and compared across studies. We did not perform a meta-ethnography. Thirty-seven studies were included,
conducted in Africa (30), Asia (4), Yemen (1), and Brazil (2). One- to three-quarters of women reported malaria episodes
during pregnancy, of whom treatment was sought by .85%. Barriers to access among women included poor knowledge of
drug safety, prohibitive costs, and self-treatment practices, used by 5%–40% of women. Determinants of women’s
treatment-seeking behaviour were education and previous experience of miscarriage and antenatal care. Healthcare
provider reliance on clinical diagnosis and poor adherence to treatment policy, especially in first versus other trimesters
(28%, 95% CI 14%–47%, versus 72%, 95% CI 39%–91%, p= 0.02), was consistently reported. Prescribing practices were
driven by concerns over side effects and drug safety, patient preference, drug availability, and cost. Determinants of
provider practices were access to training and facility type (public versus private). Findings were limited by the availability,
quality, scope, and methodological inconsistencies of the included studies.
Conclusions: A systematic assessment of the extent of substandard case management practices of malaria in pregnancy is
required, as well as quality improvement interventions that reach all providers administering antimalarial drugs in the
community. Pregnant women need access to information on which anti-malarial drugs are safe to use at different stages of
pregnancy.
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Introduction
Malaria in pregnancy is an important public health problem for
both maternal and neonatal health programmes. The manifesta-
tion of maternal infection with malaria depends on transmission
intensity, and prompt diagnosis and treatment of malaria illness in
pregnancy is important in all malaria endemic regions. Since
2006, WHO recommends quinine plus clindamycin for the
treatment of uncomplicated malaria in the first trimester, and
artesunate (AS) plus clindamycin for treatment failures. Artemi-
sinin-based combination therapies (ACTs) known to be effective in
the country/region, or AS plus clindamycin, are the recom-
mended combinations for case management of uncomplicated
malaria in the second and third trimesters [1,2]. Use of the
artemisinin class of compounds, alone or in combination therapies,
is not recommended in the first trimester of pregnancy because of
insufficient safety data in early pregnancy in humans [3], unless
this is the only treatment immediately available [1].
Many countries in high transmission settings have made ACTs
available free of charge to pregnant women in efforts to achieve
universal coverage [4]. Despite increasing availability of ACTs and
new diagnostic tools, such as rapid diagnostic tests (RDTs), very
little is known about women’s access to these interventions and
about the diagnosis and treatment practices of healthcare
providers. National malaria indicator surveys focus on access to
case management among children, the other important risk group
for malaria. Similarly, research on uptake of new diagnostics and
ACTs has to date focussed on children and non-pregnant adult
populations, whereas research on uptake of interventions in
pregnancy has predominantly focussed on progress and challenges
to the delivery and uptake of preventive interventions, namely,
intermittent preventive treatment in pregnancy (IPTp) and
insecticide-treated nets [5]. Information on access to and delivery
of effective case management of malaria in pregnancy has not yet
received the attention it deserves.
We undertook a systematic review of the factors affecting
pregnant women’s access to and health provider adherence to the
2006 WHO policy [2] on the treatment of malaria in pregnancy
globally. Among pregnant women we reviewed treatment-seeking
practices for malaria illness—the range of providers visited, the
antimalarials used, and the factors affecting their choice of
healthcare provider and medicines. We explored adherence to
policy among the range of healthcare providers administering
antimalarials to pregnant women, the type and quality of
diagnostic and case management services offered at the point of
care (including consideration of gestational age), and the health
system or other factors that affect quality of care.
Methods
Search Strategy
Studies investigating treatment-seeking practices for malaria
among pregnant women and healthcare provider case manage-
ment practices for malaria in pregnancy were identified by
searching the Malaria in Pregnancy Library [6], the Global Health
Database [7], and the International Network for the Rational Use
of Drugs (INRUD) Bibliography [8] from 1 January 2006 to 3
April 2014. The Malaria in Pregnancy Library (http://library.
mip-consortium.org) is a comprehensive bibliographic database
created by the Malaria in Pregnancy Consortium that is updated
every 4 mo using a standardised protocol to search over 40
sources, including PubMed, Web of Knowledge, and Google
Scholar. Searches were run separately for ‘‘pregnant women’’ and
‘‘health providers’’ (see Table S1 for search terms), without
language restrictions, and both peer-reviewed and grey literature
were retrieved.
Study Selection
Titles and abstracts were reviewed independently for inclusion
by two reviewers (J. Hill and L. D9M-G/J. Hoyt). Studies were
included if they met the following criteria: (1) study contained data
on treatment seeking among women and/or case management
practices for malaria in pregnancy, (2) study population included
pregnant women and/or healthcare providers, (3) study reported
original research data, and (4) study was conducted following the
introduction of ACTs for the treatment of uncomplicated malaria
in pregnancy in the study country. No restrictions were placed on
study design (i.e., quantitative, qualitative, and mixed methods
studies), or quality of reporting. Studies limited to knowledge of
malaria in pregnancy amongst pregnant women, i.e., without
information on practices, were excluded. The Kappa (K) statistic
was used as a measure of the inter-rater agreement on study
eligibility between reviewers. Discrepancies between reviewers
were resolved through discussions with a third reviewer (J. W.)
until consensus was reached.
Studies meeting the inclusion criteria were assessed and grouped
according to content. Among pregnant women primary outcomes
included (1) treatment-seeking practices for malaria, (2) barriers to
accessing malaria treatment, and (3) determinants of treatment
seeking for malaria. Among healthcare providers primary
outcomes were (1) case management practices for malaria in
pregnancy, (2) factors affecting malaria case management practic-
es, and (3) determinants of knowledge, diagnosis, and treatment of
malaria.
Data Extraction
Two authors extracted data and appraised the quality and
content of included studies. Data for pregnant women or
healthcare providers were extracted and analysed separately for
description and frequency of practices, barriers/facilitators, and
determinants (Figure 1). Two authors (J. Hill and L. D9M-G/A.
M. v. E/J. Hoyt) extracted quantitative data on the type and
frequency of practices from quantitative and mixed methods
studies. For pregnant women these quantitative data included the
frequency of malaria episodes, sources of treatment, and the
resultant treatment achieved, and for healthcare providers the
quantitative data included the type and frequency of diagnostic
and treatment practices in relation to national drug policy at the
time of publication. J. Hill and L. D9M-G/J. Hoyt extracted
qualitative and quantitative data on the barriers and facilitators to
treatment seeking among pregnant women and case management
practices among healthcare providers from qualitative and mixed
methods studies. J. Hill and L. D9M-G/J. Hoyt extracted
quantitative data on the determinants of treatment seeking and
case management practices among pregnant women and health-
care providers, respectively, from quantitative and mixed methods
studies. For healthcare providers, determinants of knowledge and
practice, and of diagnosis and treatment, were extracted
separately. Two authors (J. Hill and L. D9M-G/J. Hoyt) assessed
the quality of reporting of individual studies using a checklist of
criteria developed a priori based on criteria and methods described
in the literature, described previously [5].
Data Synthesis and Analysis
Narrative synthesis was used to summarise, compare, and
contrast the type, range, and frequency of practices from each
study evaluating treatment seeking among pregnant women and
case management practices among healthcare providers. To make
Access to Case Management of Malaria in Pregnancy
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a comparison between national policy and healthcare provider
practices by country and region, we used the national or global
malaria policy cited in the included studies.
Barriers and facilitators were explored using content analysis
with a previously defined thematic framework for pregnant
women and healthcare providers [5]. NVivo version 9.2 (QSR
International) was used to generate an index of codes, which
identified each of the recurring barriers amongst pregnant women
and healthcare providers. The themes emerged as all the data
were analysed, working cyclically through the studies. Data from
the women’s perspective were categorised into individual, social/
cultural/household, environmental, and health system levels. Data
from providers were synthesised into a matrix that combined
operational levels of individual, organisational, health system, and
non-health system levels, together with the six health systems levels
of the WHO Health Systems Framework, which include
governance/leadership, service delivery, health workforce/human
resources, health information systems, finance, and medical
products/technologies [9–11].
We appraised the quality of reporting of each study using a
checklist of criteria based on methods described in a previous
review [5], as described and reported in Tables S2–S4.
Statistical Analysis
We pooled the frequency data for source of treatment among
pregnant women and adherence to treatment policy among
healthcare providers across different types of providers using
random effect meta-analysis in Stata version 12 (StataCorp) and
Comprehensive Meta-Analysis (Biostat; http://www.meta-
analysis.com/), which was also used for sub-group analysis. We
used forest plots to visualise the extent of heterogeneity between
studies. For studies that reported source of treatment for more
than one episode of fever, we included the response to the first
episode [12]. For source of treatment among pregnant women, we
conducted sub-group analysis within each category for the
following: whether the question involved practice (i.e., women
with fever) or attitude (i.e., a hypothetical question, ‘‘if they had
fever…’’); health facility– or population-based enrolment; urban
or rural populations; and country of study (Nigeria, the country
contributing the majority of studies, versus other countries). For
adherence to treatment policy, we conducted sub-group analysis
for the following: trimester treated, the effect of staff cadre
(medical doctor versus others), and method of data collection (self-
administered questionnaire, interview, or record review). I2 was
used to quantify heterogeneity [13].
Results
Of 2,047 records retrieved from the database searches, 37
studies met the inclusion criteria (Figure 2)—13 studies in
pregnant women, 18 studies in healthcare providers, and six
studies in both pregnant women and healthcare providers; only
one study evaluated interventions. There was close agreement
between the reviewers on the review of full text articles (K= 0.84).
The majority of studies were conducted in Africa (30), with only
four studies conducted in Asia (two in India [14,15] and two in
Figure 1. Analysis strategy.
doi:10.1371/journal.pmed.1001688.g001
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Cambodia [16,17]), one in Yemen [18], and two in Brazil [19,20].
Of the studies conducted in Africa, 17 were in west and central
Africa and 12 in east and southern Africa, and one study had sites
in east, west and southern Africa [21]. All but three studies were
cross-sectional surveys at the population or facility level. The
remaining studies included two longitudinal qualitative studies
[21,22] and a randomised controlled trial [23]. The study
characteristics are provided in Tables 1–3.
Quality of about half (14/27) of the quantitative studies was
assessed to be moderate-high (scored 6–8/10), with ten low-
moderate-quality studies (4–5/10) and three high-quality studies
(9–10/10) (Table S2). The quality criterion least often met among
these studies was the use of multivariate analysis. The four
qualitative studies were assessed as moderate-high quality (4–7/8),
with only one of the studies reporting saturation of themes (Table
S3). All six mixed methods studies were assessed as high quality (9–
10/11), though only one study reported use of multivariate
analysis (Table S4). Data on frequencies of practices, barriers/
facilitators, and determinants of access among women were
extracted from 13, 15, and four studies, respectively, and of policy
adherence among healthcare providers, from 24, 22, and ten
studies, respectively (Table 4).
Pregnant Women Perspectives
The 19 studies that contributed data on the treatment-seeking
practices of pregnant women were undertaken in ten countries
across Africa (seven studies in east Africa, eight in west Africa, one
in southern Africa, one in central Africa, and one with sites in east,
west, and southern Africa) and in one country in Asia (Tables 1
and 3).
Description and frequency of practices among pregnant
women. The proportion of women reporting at least one
episode of malaria during their current or recent pregnancy
ranged from 25% to 75% of respondents in three population-
based [24–26] and three facility-based [14,27,28] studies in Africa
and Asia, with between 30% and 46% of women reporting two or
more episodes in Africa [25,27,28] (Tables 5 and 6). Of one
population-based [25] and three facility-based [14,28,29] studies,
a high proportion (.85%) of women with a reported episode of
malaria during pregnancy sought some form of treatment.
Pregnant women in three population-based [26,30,31] and
seven facility-based [12,14,22,27–29,32] studies in Africa reported
self-medication or treatment at a pharmacy/drug store at the onset
of fever (range 5%–40%), and attended a health facility only if
their fever did not respond to this treatment [12,30] (Tables 5 and
6). In southern Ghana, women seeking treatment at a pharmacy or
drug vendor without a clinic prescription reported that the
antimalarials were selected by either the shop attendant (21% and
26% in rural and urban areas, respectively) or themselves (8% and
10%, respectively) [30]. Use of local herbs was a first resort among
pregnant women in a population-based study in Nigeria [33].
Pregnant women in urban settings were likely to seek care from
Figure 2. PRISMA chart of studies included in the review.
doi:10.1371/journal.pmed.1001688.g002
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antenatal care (ANC) or health facilities as a first resort, as
observed in three population-based studies in Nigeria (42%) [24],
Sudan (82%) [31], and internally displaced person (IDP) camps in
Uganda (86%) [26], and five facility-based studies (range 63%–
92%) in Ethiopia [32], Nigeria [27–29], and India [14].
Data on sources of treatment extracted from nine studies
showed high heterogeneity across studies (I2 ranging from 60% to
99%) (Figure 3), and all but one study [12] were of moderate to
high quality. Site of enrolment (health facility– versus population-
based), country (Nigeria versus other countries), and type of
question (practice versus attitude) had no effect within each
category (Table S5). Compared to urban women, rural women
were more likely to make use of a traditional healer or herbs (2%,
95% CI 0%–7%, three studies, versus 21%, 95% CI 6%–52%,
four studies, respectively, p=0.008), whereas urban women made
more use of health facilities (84%, 95% CI 71%–91%, two studies,
versus 38%, 95% CI 14%–70%, four studies, p=0.006).
Only six of the 14 studies among pregnant women with
treatment-seeking practice as a primary outcome included
quantitative data on use of ACTs, and of these, only four stratified
use by trimester. In a household survey in Uganda, among first
trimester episodes, quinine was used in only 6% of first trimester
cases, with .80% of episodes treated with drugs not recom-
mended for use in the first trimester either because they are
contraindicated (sulphadoxine-pyrimethamine [SP] and arte-
mether-lumefantrine [AL]) or because of high-grade drug
resistance (chloroquine [CQ]) [25]. Only 30% of second and
third trimester cases adhered to national guidelines (AL or quinine)
[25]. Another study conducted in 2011 in Uganda reported
appropriate treatment in only 36% of febrile cases, defined as
parasite-positive pregnant women given AL (Coartem) and
parasite-negative women given no antimalarial drug [34]. Of
pregnant women interviewed at a public hospital in Tanzania,
31% had used AL for an episode of malaria in the index
pregnancy, 27% SP, 23% quinine, 16% sulphalene-pyrimeth-
amine, and 3% amodiaquine (AQ) [35]. The majority (82%) of
women said they were asked about gestational age before being
given AL by drug dispensers; however, only 17% of pregnant
women were aware that AL should not be taken in the first
trimester, and only 22% knew that quinine was recommended. In
a population-based study in Ghana, drug sellers said some women
requested artemisinin combinations for treatment in the first
trimester [30].
A household survey in southeast Nigeria found that 42% of
pregnant women who had a fever within the last month had visited
a health facility, of which 46% were treated with ACTs, 34% with
SP, and 4% with artemisinin monotherapy; however, trimester
was not specified [24]. In an earlier population-based study in
Nigeria, women reported a high preference for SP for case
management in the second and third trimesters of pregnancy,
whereas the national treatment policy in second and third
trimesters was to use AL; the study was, however, done only a
year after the new policy was introduced [33]. A more recent
facility-based study in a teaching hospital reported that quinine
was used in only 12% of first trimester episodes, with artemisinin-
containing compounds, SP, and CQ used in 35%, 39%, and 14%
of cases, respectively [28]. In a comparative study of treatment
practices of second and third trimester episodes in public and
private health facilities, quinine was used in 4% of episodes in both
types of facility, with artemisinin monotherapy constituting the
most frequently prescribed drug (36%–39%) [29].
Barriers to care seeking for malaria among pregnant
women. The factors affecting treatment seeking for malaria
most frequently cited in the content analysis related to the
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following: women’s knowledge and perceptions of risk, perceptions
and experience of drug safety, cost, and perceptions and
experience of healthcare provider and health facility factors
(Table 7). Women in one facility-based study [14] perceived
malaria during pregnancy as not especially dangerous, and the first
response in two population-based [30,31] and four facility-based
[12,14,22,32] studies was to rely on self-medication or herbal
treatments, and to seek medical advice only if the illness did not
improve. Over 50% of women in a facility-based study reported
delaying .2 d after first noticing symptoms before seeking care
Table 4. Data extracted for frequencies, barriers, and determinants by survey type.
Study Pregnant Women
{ Healthcare Providers?
Frequencies Barriers Determinants Frequencies Barriers Determinants
Facility-based studies
Bin Ghouth 2013 [18] ! ! !
Kiningu 2013 [41] ! ! !
Luz 2013 [19] ! !
Luz 2013 [20] ! !
Mbonye 2013 [34] !
Obieche 2013 [28] ! !
Onwujekwe 2013 [29] ! !
Harrison 2012 [43] ! ! !
Minyaliwa 2012 [51] ! !
Okoro 2012 [40] ! !
Onwujekwe 2012 [39] ! ! !
Kamuhabwa 2011 [35] ! ! ! ! ! !
Manirakiza 2011 [36] ! ! !
Smith Paintain 2011 [47] ! ! !
Umar 2011 [38] ! ! !
Karunamoorthi 2010 [32] ! !
Launiala 2010 [22] !
Maiga 2010 [12] ! !
Sabin 2010 [14] ! !
Smith Paintain 2010 [23] !
Wylie 2010 [15] ! ! !
Enato 2009 [27] ! !
Omo-Aghoja 2008 [37] ! ! !
PSI 2007 [16] ! !
Population-based studies
Pell 2013 [21] ! !
Enato 2012 [44] ! !
Mbachu 2012 [24] ! ! !
Henry 2012 [26] ! !
Kalilani-Phiri 2011 [42] ! !
Kwansa-Bentum 2011 [30] ! ! ! !
Okonta 2011 [46] ! !
Sangare´ 2011 [25] ! ! !
Stangeland 2011 [45] ! !
Mbonye 2010 [52] ! !
Adam 2008 [31] ! !
Sam-Wobo 2008 [33] ! !
Tawfik 2006 [17] ! !
Summary total 13 15 4 24 22 10
{Pregnant women: for frequency data, see Tables 5 and 6; barrier data, Table 7; determinant data, Table 8.
?Healthcare provider: for frequency data, see Tables 9 and 10; barrier data, Table 11; determinant data, Table 12.
PSI, Population Services International Research and Metrics.
doi:10.1371/journal.pmed.1001688.t004
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[27]. The choice of treatment was influenced by women’s
perceptions of the safety of drugs used during pregnancy, as
reported by three population-based studies [30,31,33] and one
facility-based study [35]. Fear and/or prior experience of side
effects to drugs also influenced treatment choices and adherence,
as reported by one population-based [21] and three facility-based
[14,23,35] studies. In northern Ghana, pregnant women identified
contradictions between messages provided in health facilities and
their own experiences of malaria [21].
The high cost of treatment prevented pregnant women from
using the formal health sector in rural population-based surveys in
Ghana [21,30], Kenya [21], and Nigeria [24]. Poverty was said to
be why women resorted to herbal remedies in Kenya and Ghana,
to avoid costs of both transport and medical care [21]. Other
barriers cited were user fees at formal health services [33] or the
cost of treatment in urban areas in population-based surveys in
Ghana [30] and facility-based studies in the Central African
Republic (CAR) [36] and India [14]. Lack of adequate care at
Figure 3. Prevalence of source of malaria treatment during pregnancy assessed in 18 studies with quantitative data. hf, health
facility–based survey; pb, population-based survey.
doi:10.1371/journal.pmed.1001688.g003
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health facilities [23] was an additional deterrent to using the health
facilities. Women in one study reported that they did not
understand the instructions given by dispensers regarding (AL)
dosage and duration of use [35]. On the other hand, women who
were concerned for their pregnancy status, who were aware of the
treatment options [22,23,30] and considered the drugs safe and
effective [14,25,30,35], and who trusted the health facility staff
[21,23] were more likely to seek treatment at health facilities.
Women in Ghana and Kenya generally valued diagnostic tests for
malaria (and other diseases) and associated testing with more
effective treatment [21].
Determinants of care seeking for malaria among
pregnant women. The range of determinants of treatment
seeking among pregnant women explored across the included
studies included education, prior experience of miscarriage, and
ANC use. The key findings are highlighted in Table 8; insufficient
data and lack of consistency in the indicators used prevented us
from performing a meta-analysis of pooled data. A higher level of
education was associated with correct knowledge of AL use in
pregnancy in Tanzania [35]. Prior use of ANC services and
previous experience of miscarriage were associated with increased
treatment seeking for malaria in IDP camps in Uganda [26].
Healthcare Provider Perspectives
The 24 studies that contributed data on the diagnosis and
treatment practices of healthcare providers were undertaken in ten
countries, involving a range of cadres, including medical doctors
and nurses, pharmacists, drug vendors, traditional birth attendants
(TBAs), and community health workers (CHWs) (Tables 2 and 3).
Description and frequency of diagnostic practices. Malaria
diagnosis in pregnancy by public healthcare providers in the studies
conducted in Africa was predominantly performed on the basis of
clinical symptoms, as reported by one population-based study in
Ghana [30] and five facility-based studies in CAR [36] and Nigeria
[37–40]. The exceptions to this were microscopy use by private
sector providers in Nigeria [39] and by a provincial hospital in
Kenya [41] (Table 9). One population-based study in Malawi [42]
and three facility-based studies in Nigeria [37,38,43] reported a
combination of clinical and parasitological diagnosis by microscopy.
Providers at the community level in three population-based studies,
including private providers in Cambodia [17] and TBAs in Africa
[44,45], relied exclusively on clinical symptoms unless women could
produce prescriptions issued from clinics. Globally, few studies
reported healthcare providers using RDTs. In Africa, reports of
RDT use have been relatively recent (2011 inMalawi [42] and 2012
in Nigeria [39]), compared to in Asia (2007 in Cambodia [16]), and
only a fraction of providers reported using RDTs (range 22%–34%)
[16,39,42]. In a population-based survey of medical doctors and
pharmacists in Malawi, availability of tests, patient symptoms, and
cost were the main factors affecting choice of diagnostic test [42]. In
an observational study of ANC visits in eastern India, blood tests
were typically obtained if a patient complained of fever, though
enquiries into presence of fever in patients were made in only a
minority of patients [15].
Description and frequency of treatment knowledge and
practices. In west and central Africa, 11 studies on health
providers were conducted in Nigeria (eight studies), Ghana (two),
and CAR (one), where the national antimalarial treatment
guidelines stipulate quinine for treatment of uncomplicated malaria
in the first trimester and an ACT in the second and third trimesters
[30,36,39] (Table 10). Only two of the eight studies in Nigeria
[28,37–40,43,44,46] reported a relatively high proportion of
providers adhering to treatment policy. Onwujekwe et al. found
that more doctors, pharmacists, and nurses providing ANC services
Table 8. Data on the determinants of treatment-seeking behaviours for malaria in pregnancy by pregnant women.
Determinant Study Country Scale N Details
Age Kamuhabwa 2011 [35] Tanzania ,1 district 200 Age is not associated with knowledge of AL use in pregnancy
Henry 2012 [26] Uganda 1 district 769 Age is not associated with increased treatment seeking
Education Kamuhabwa 2011 [35] Tanzania ,1 district 200 A higher level of education in women was associated with correct
knowledge of AL use in pregnancy (p,0.001)
Henry 2012 [26] Uganda 1 district 769 Women’s level of education was not associated with increased
treatment seeking
Marital status Henry 2012 [26] Uganda 1 district 769 Marital status was not associated to increased treatment seeking
Parity/gravidity Kamuhabwa 2011 [35] Tanzania ,1 district 200 Parity/gravidity was not associated with knowledge of AL use in
pregnancy
Henry 2012 [26] Uganda 1 district 769 Gravidity was not associated with increased treatment seeking
Sangare´ 2011 [25] Uganda 1 district 500 There was no difference between multiparous and primiparous
women in their use of the recommended dosage of treatment
Gestational age Kamuhabwa 2011 [35] Tanzania 1 district 200 Age of gestation was not associated with knowledge of AL usage
in pregnancy
Henry 2012 [26] Uganda 1 district 769 Age of gestation was not associated with increased treatment
seeking
Experience of
miscarriage
Henry 2012 [26] Uganda 1 district 769 Prior experience of miscarriage was associated with increased
treatment seeking (p=0.049)
Prior use of ANC Henry 2012 [26] Uganda 1 district 769 Prior use of ANC services by women was associated with increased
treatment seeking (p=0.029)
SES Mbachu 2012 [24] Nigeria 1 district 898 SES of women was not associated with the utilisation of different
antimalarials by pregnant women
All effects measured using the Chi-squared test.
SES, socio-economic status.
doi:10.1371/journal.pmed.1001688.t008
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in public than private sector hospitals adhered to the national policy
of prescribing ACTs in the second and third trimesters (69% versus
5%); private hospitals predominantly prescribed SP (70%) [39].
More public than private sector providers prescribed quinine in the
first trimester (35% versus 15%); private sector providers predom-
inantly prescribed SP (65%). Okonta found that whilst 56% of
doctors had prescribed quinine during the first trimester, the fear of
quinine causing miscarriage was a significant consideration, with all
but one physician prescribing quinine at lower than the recom-
mended dose, and showing a preference for CQ [46]. Similarly,
Okoro and Nwambu found very low prescription of quinine in the
first trimester (2.5%), and ACTs constituted 51% and 29% of
antimalarial drugs prescribed in the second and third trimesters,
respectively [40]. Two studies did not stratify treatment drug by
trimester [37,43]. Up until 2012, SP continued to be used widely for
case management of clinical malaria in pregnancy in Ghana [30,47]
and Nigeria [28,37–40,43], as well as CQ, despite its known
resistance [37,39,43], and artemisinin monotherapies [37,43,46].
In Ghana, Kwansa-Bentum et al. found clinicians prescribing
quinine for malaria treatment in the first trimester of pregnancy,
per policy, but also SP, and predominantly ACTs were prescribed
in the second and third trimesters, though SP and quinine were
also prescribed [30]. In the same study, drug sellers reported
pregnant women requesting, in order of preference, SP, ACTs, or
quinine, with no difference by trimester. Smith Paintain et al.
found that few ANC providers (20%) demonstrated good
knowledge of the dosing regimen for treatment in the first
trimester, though knowledge that AS-AQ should be prescribed in
subsequent trimesters was better (42%), with preference for AS-
AQ over quinine due to the side effects and long regimen duration
(7 d) of quinine [47]. In CAR, 29% of ANC cards of women who
had delivered in a maternity unit contained at least one
antimalarial prescription, of which 57% were for quinine, 27%
for ACTs, and 14% for artemisinin monotherapies; 11% and 13%
of ACTs and artemisinin monotherapies, respectively, were for
treatment in the first trimester [36].
In east and southern Africa, six studies were conducted in Kenya
(one study), Malawi (two), Tanzania (one), and Uganda (two),
where, again, the national malaria treatment policies recommend
quinine in the first trimester, with an ACT (AS-AQ or AL) for the
second/third trimester [48–50]. In Kenya, while 83% of staff at a
provincial hospital stated that they used the national guidelines,
guidelines were available at only 25% of points of use, and 73% of
pregnant patients received parenteral quinine [41]. In Malawi,
Kalilani-Phiri et al. found that only 40% of medical doctors and
pharmacists knew the treatment guidelines for uncomplicated
Figure 4. Prevalence of adherence to treatment policy for malaria in pregnancy assessed in 15 studies with quantitative data. Pf, P.
falciparum; Pv, P. vivax; self-administered, self-administered questionnaire; MiP, malaria in pregnancy.
doi:10.1371/journal.pmed.1001688.g004
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malaria in pregnant women, compared to 83% for severe malaria
[42]. In contrast, Minyaliwa et al. reported that a high proportion
(91%) of providers were cognisant of the appropriate drugs to use in
each trimester, though specific drug names were not reported [51].
A study of dispensing practices among private pharmacies in urban
Tanzania found low knowledge of appropriate antimalarial drugs,
with 33% of providers willing to dispense AL for use in the first
trimester and 36% indicating it could not be used in pregnancy.
Nevertheless, 82% of women reported that they were asked about
gestational age before they were given AL. Pharmacists and nurse
assistants had better AL knowledge than pharmaceutical techni-
cians and sales persons [35]. In Uganda, Mbonye and Magnussen
found that 38% of pregnant women with reported fever but
negative blood smears received an antimalarial (drug not specified)
in addition to IPTp [52].
The remaining studies were conducted in Cambodia (one study)
and Brazil (two studies). In Cambodia, only 4/27 pregnant women
surveyed received the recommended drug, quinine, in the first
trimester, and knowledge amongst private providers about first
line treatment for malaria in pregnancy was poor [17]. In Brazil,
while 93% of patients received the recommended first line therapy
for Plasmodium vivax malaria, only 45% of patients received the
recommended first line therapy for P. falciparum malaria, with
7% and 18% of prescriptions, respectively, not sanctioned by
national guidelines [20].
Meta-analysis of adherence to treatment policy. Frequency
data on adherence among healthcare providers to treatment policy
by trimester, extracted from 12 studies, showed wide heterogeneity
(overall I2 98.6%) (Figure 4), and all but one study [51] were of
moderate to high quality. There was lower adherence to treatment
Figure 5. Integration of findings in relation to WHO case management policy [1]. LBW, low birth weight.
doi:10.1371/journal.pmed.1001688.g005
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policy in the first trimester (28%, 95% CI 14%–47%, nine entries
from seven studies) than in the other trimesters (72%, 95% CI 39%–
91%, five entries from three studies), and this difference was
significant in the sub-group analysis (p=0.02) (Table S6). Studies
describing practices among doctors (three entries from Nigeria, 269
doctors in total as defined by the local researchers, all self-
administered questionnaires) found that these healthcare providers
were significantly less likely to prescribe correctly (11%, 95% CI 4%–
23%) than healthcare providers in studies describing practices among
other staff or mixed cadres (18 entries, 52%, 95% CI 35%–67%, p,
0.001). Studies conducted by self-administered questionnaires showed
a significantly lower proportion of adherence to treatment policy
(14%, 95% CI 7%–28%, six entries) than studies using interviews
(50%, 95% CI 27%–73%, seven entries) or record reviews (66%,
95% CI 39%–86%, eight entries, p=0.001), and studies describing
practices in Nigeria were significantly less likely to report correct
treatment (25%, 95% CI 12%–46%, ten entries from eight studies)
than studies in all other countries combined (58%, 95% CI 40%–
75%, 11 entries from eight countries, p=0.018).
Barriers to effective case management practices for
malaria in pregnancy among healthcare providers. Factors
affecting diagnostic and case management practices occurred at all
levels of the health system and across all of the health system building
blocks (Table 11). Reliance on clinical diagnosis in the absence of
parasitological confirmation by microscopy or RDT is a major
weakness to effective management of malaria in pregnancy in many
study settings. Parasitological diagnosis was not always possible
because of inadequate or lack of diagnostic facilities
[15,17,21,42,43,47] or prohibitive costs to women [17,42]. One
study noted concerns among providers about the poor predictive
value of microscopy, with providers administering treatment to
women with negative blood smears [52]. In Cambodia, monovalent
RDTs that detected only P. falciparum were available at the village
level; hence, people with a negative result were reported to self-treat
for P. vivax [17].
Poor knowledge of and adherence to national treatment policy
guidelines among healthcare providers was a consistent finding
across countries in east [42,51] and west Africa
[21,30,37,38,40,43,44,46,47], Asia [16,17], the Middle East [18],
and Latin America [20], and knowledge was particularly poor
among private providers [35,39]. In Ghana, healthcare providers
asserted that pregnant women were exceptions to the policy of
testing prior to treatment, and provided treatment even when a
malaria test was negative. This practice was a misinterpretation of
the guidelines, which state that in the absence of a laboratory,
pregnant women with clinical symptoms of malaria should be
treated [21]. Financial incentives and client demand have been
reported to motivate private practitioners to sell medicines, even
inappropriate medicines or more expensive brands [40], without
parasitological testing [17]. Prescription practices were influenced
by perceptions of low drug efficacy [20,37,38,46], perceptions of
increasing drug resistance [17,38], concerns about drug safety
[35,37,46], inadequate understanding and fear of potential side
effects of drugs in pregnancy [17,35,40,46,47,51], and the
influence of patient preference [17], each contributing to poor
quality of care. Many of the substandard practices reported are a
consequence of factors operating at higher levels of the health
system. Lack of national guidelines in India led to healthcare
provider confusion about treatment policy [15]. Elsewhere, lack of
training for diagnosis [16,20] and/or treatment [18,20,41–43,51]
and lack of supervision [16,41,47] contributed to poor service
delivery. Poor provider knowledge was exacerbated by weak
organisation at the level of the health facility, such as inadequate
drug stocks [15], and poor record-keeping practices such as
providing written prescriptions and infrequent recording of vital
information [20] and clinical findings and diagnoses [36] in both in-
patient and out-patient records. Health system policies on fees for
diagnosis [17,42] and prescription drugs [17,30,38,41,42,46] and
human resource constraints [41,47] also constitute important barriers.
Determinants of knowledge and diagnostic and treatment
practices among healthcare providers. Determinants of
healthcare provider knowledge, diagnostic practices, and treat-
ment practices explored across the different studies included the
following: individual healthcare provider factors (cadre, training),
type of facility (public or private; primary or tertiary), and region/
location (Table 12). There was insufficient uniformity of indicators
and determinants to perform a meta-analysis of pooled data.
Cadre of healthcare provider was associated with correct
treatment knowledge [47] and diagnostic practices [38]. Public
sector providers were more likely to use clinical diagnosis or
parasitological diagnosis with RDTs and to adhere to national
guidelines than private providers in Nigeria [39]. Two studies
assessed the impact of training on provider knowledge, finding a
significant positive association between provider knowledge and
recent training on malaria treatment guidelines [18,47].
Intervention studies. Only one intervention study was
identified, which evaluated the effect of in-service training of
clinicians and pharmacists in the private sector in three
governorates in Yemen on malaria treatment in pregnant women
[18]. The post-training assessment showed improved knowledge of
correct dosing, from 17% to 60%, still far short of 100%.
Discussion
To our knowledge this review draws together for the first time
findings from disparate studies on the treatment-seeking practices
for malaria in pregnant women and the case management
practices of a range of healthcare providers globally. The key
emerging themes are relatively consistent across a range of study
settings in terms of local cultural, socio-economic, health system,
and non–health system contexts, and geographical locations. One-
to three-quarters of women reported malaria illness during
pregnancy, of whom treatment was sought by .85%. Self-
medication and traditional healers were reportedly used by 5% to
40% of women, alongside care from the formal health sector
(range 42%–92%). Knowledge of drug safety, cost, and percep-
tions of healthcare services affected treatment choices. Determi-
nants of treatment seeking were education and prior experience of
miscarriage or ANC use. Healthcare providers’ reliance on clinical
diagnosis and poor adherence to treatment guidelines by trimester
were consistently reported. Prescribing practices were driven by
poor knowledge of national guidelines and concerns over side
effects and drug safety, patient preference, drug availability, and
cost. Determinants of provider practices were individual provider
factors (cadre, training), facility type (public or private; primary or
tertiary), and sub-national region.
The review highlights important limitations in the implemen-
tation of the WHO policy on treatment of malaria in pregnancy
[1,2]. There is an apparent disconnect between the theories that
underpin WHO policy and the beliefs and attitudes of women, in
addition to which there is dissonance between the principles of
delivery of quality care, and the experiences and practices of
pregnant women and healthcare providers (Figure 5). Importantly,
women do not uniformly seek care within the formal health
system, and when they do, they may not access appropriate
diagnosis and treatment, because of poor healthcare provider skills
or inadequate resources or because they cannot afford to pay for
the services.
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Barriers to access among women—in particular, poor knowl-
edge of drug safety, prohibitive costs, and self-treatment practic-
es—suggest ministries of health need to improve women’s access to
information so that they can make informed choices. Educating
women about the risks of malaria in pregnancy will be important,
especially as the manifestation of malaria illness in pregnancy may
be confused with pregnancy-related symptoms [53]. Even when
women think they have malaria, a series of socio-cultural factors
impede women’s ability to act, such as not wishing to disclose their
pregnancy status and other factors operating at the household level
that restrict women’s autonomy to seek care, as reported by others
[17,53,54]. The finding that pregnant women may self-treat for
malaria was partly attributed by the reviewed studies to the
irregular and inadequate supply of drugs at health facilities. Given
that alternative care providers include shop vendors (who are
poorly informed or otherwise incentivised to give more expensive
and sometimes inappropriate drugs) and TBAs (who practice and
promote herbal remedies and traditional herbs as healthier or less
risky to the developing foetus) [45], women need appropriate
information about which antimalarials are recommended and safe
to use for the treatment of malaria at different stages of pregnancy.
Advertising provides an opportunity for governments to add
messages about safety and use of antimalarials in pregnancy, and
information pamphlets could be given to women at ANC facilities.
One of the main barriers to women seeking treatment for malaria
at formal health facilities is cost, both direct costs such as user fees
and indirect costs, as has been reported in studies on antenatal
care seeking more broadly [55,56]. The economic barriers to
accessing expensive diagnostic tests and treatment for malaria
among pregnant women have been reported previously [57] and
warrant a review of strategies to reach pregnant women with safe
and affordable treatment options.
Diagnosis of malaria in pregnancy in many settings is
challenging. In stable and high transmission settings, parasitolog-
ical diagnosis based on microscopy or RDTs potentially reduces
the unnecessary use of antimalarials in pregnancy, particularly in
areas of high HIV prevalence, where HIV-infected patients have a
high incidence of febrile illness [2]. As our review shows, the reality
in resource-constrained public health facilities and among
community providers is that diagnosis is frequently restricted to
clinical symptoms. As observed in a clinical study among pregnant
women in Mozambique, the positive predictive values of the three
most common malaria symptoms—headache, arthromyalgias, and
history of fever—for malaria parasitaemia were low (28%, 29%,
and 33%, respectively) [58]. Even where diagnostic tests are
available, studies reported that providers sometimes choose to
ignore negative test results and prescribe antimalarials when
malaria is suspected. The reasons for ignoring diagnostic test
results are likely to be a combination of factors related to user
preferences and demand, suspected insensitivity or inferiority of
the tests, inferior reagents, or lack of trust in the accuracy of slide
reading by laboratory staff. Efforts are needed to scale up the
availability of RDTs at points of care used by pregnant women
and to improve provider proficiency in their application.
Healthcare providers from a range of countries and continents
and across a variety of cadres in the private and public sectors, and
formal and informal sectors, demonstrated poor knowledge of and
adherence to national treatment policy guidelines. Poor knowledge
of and availability of treatment guidelines, and concerns over side
effects and drug safety suggest the need for refresher training, job
aids, and improved supervision. The finding that doctors were less
likely to prescribe correctly may reflect personal judgements based
on knowledge or individual client needs, as noted in a study in
Zimbabwe where many practitioners felt that guidelines would
limit their personal flexibility in caring for patients [59]. Health
system strengthening is needed to improve drug availability, as
well as legislation to promote rational drug use to eliminate the use
of monotherapies and other non-recommended antimalarials
across all service providers. Efforts by ministries of health to
incorporate private sector providers into centralised training and
dissemination activities on national treatment policy are needed.
In addition, a licensing system to regulate which antimalarials are
sold at the community level is needed to prohibit the use of
monotherapies and to reduce women’s exposure to ineffective
drugs and the potential risks of ACT use in the first trimester.
With the advent of the 2006 WHO policy [2], inadvertent
exposure to ACTs among pregnant women in the first trimester
has been a considerable public health concern [3,60]. Few studies
in our review stratified antimalarial use by trimester; of those that
did, prescription of ACTs in the first trimester was reported in
Ghana, CAR, and Nigeria. This is a very real concern, and
research by the Malaria in Pregnancy Consortium is ongoing to
develop pharmacovigilance systems that can be implemented in
resource-poor countries to monitor the safety of antimalarials in
pregnancy, including inadvertent exposures in the early first
trimester [61]. The continued use of drugs that are no longer
recommended in national treatment policies, such as SP (recom-
mended for IPTp only) in Ghana and Nigeria, and CQ in Nigeria
(because of known high levels of parasite resistance to CQ) [62], is
another area for concern. The use of artemisinin monotherapies is
a major threat for the development of artemisinin resistance in the
Africa region, as occurred in parts of Asia [63,64].
The dearth of implementation research on interventions to
improve the quality of case management of malaria in pregnancy
underscores the fact that this is a neglected area of research,
despite case management constituting one of the three key
strategies for controlling malaria in pregnancy in sub-Saharan
Africa, and a lifesaving intervention for both mother and child in
lower transmission settings in Asia and Latin America. Research
using standardised methodologies is needed to systematically
document treatment seeking in pregnant women and healthcare
provider practices across a range of countries and settings.
Implementation research is needed to evaluate the impact of
strengthened public sector practices on pregnant women’s access
to malaria treatment in the public sector, as well as strategies that
target private drug sellers, such as better information, communi-
cation, and legislation for rational drug use.
Strengths and Limitations
The review uses data from quantitative, qualitative, and mixed
methods studies to increase the comprehensiveness of the review;
studies with quantitative data provided frequencies of practices,
the qualitative data provided important explanatory factors
driving those behaviours, and the content analysis was useful to
determine the frequency of reporting of the different factors
associated with case management of malaria in pregnancy across
studies. We did not attempt a meta-ethnography, as has been done
by others [53]. The primary geographic scope of the review is
Africa, since this is where the majority of the included studies were
undertaken, with few available studies in Asia and Latin America.
Whilst no restrictions were placed on the language, and no studies
were excluded on the basis of language, the focus of the Malaria in
Pregnancy Library (the primary source of studies) to date has been
the European family of languages, predominantly English.
Reviewer bias was limited by the use of two reviewers to
independently assess inclusion criteria. The reporting of the
included studies was assessed for quality, and reporting quality for
the majority of studies was assessed to be moderate to high.
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Findings from five studies [12,35,44,51,52] assessed to be of low
quality (meeting ,50% of the quality criteria) were consistent with
the other studies. Inconsistency in study methodologies and end
points precluded a meta-analysis of pooled data of the determi-
nants of women’s access to treatment or healthcare provider case
management practices. In the meta-analysis for source of
treatment, there may have been overlap between sources of
treatment reported, e.g., a doctor may practice in a health facility,
antenatal clinic, or private clinic.
The majority of studies of women were undertaken at sub-
district, district, or state level, which limits the generalisability of
the individual studies. There was reasonable consistency of
findings across different studies in the same country and across
studies in different countries. The studies of healthcare providers
had greater geographic scope, with eight of 18 studies undertaken
in more than one district or state, three of which were done at
national level.
Conclusions
Our review highlights the poor quality of case management
practices for malaria in pregnancy across many parts of Africa,
Asia, and Latin America. These practices not only threaten the
health outcomes for mothers and their infants, but endanger the
prospective useful life of several therapeutic drugs, in particular the
artemisinins, through the continued use of monotherapies. The
challenge for ministries of health will be the deployment of
legislative and quality improvement interventions to reach the
broad range of healthcare providers that administer antimalarial
drugs in the community, in the private and public sectors as well as
in the formal and informal sectors. Further implementation
research using standardised methodologies is needed to systemat-
ically assess the extent of substandard case management practices
at the national scale, to review how policies are implemented and
disseminated by countries, and to assess practitioner and patient
adherence. Research to evaluate targeted or multifaceted inter-
ventions aimed to improve the delivery of and access to quality
case management services for pregnant women should be a
priority.
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Editors’ Summary
Background. Malaria, a mosquito-borne parasite, kills
about 600,000 people every year. Most of these deaths
occur among young children in sub-Saharan Africa, but
pregnant women and their unborn babies are also vulner-
able to malaria. Infection with malaria during pregnancy can
cause severe maternal anemia, miscarriages, and preterm
births, and kills about 10,000 women and 100,000 children
each year. Since 2006, the World Health Organization (WHO)
has recommended that uncomplicated malaria (an infection
that causes a fever but does not involve organ damage or
severe anemia) should be treated with quinine and clinda-
mycin if it occurs during the first trimester (first three
months) of pregnancy and with an artemisinin-based
combination therapy (ACT) if it occurs during the second
or third trimester; ACTs should be used during the first
trimester only if no other treatment is immediately available
because their safety during early pregnancy has not been
established. Since 2010, WHO has also recommended that
clinical diagnosis of malaria should be confirmed before
treatment by looking for parasites in patients’ blood
(parasitology).
Why Was This Study Done? Prompt diagnosis and
treatment of malaria in pregnancy in regions where malaria
is always present (endemic regions) is extremely important,
yet little is known about women’s access to the recom-
mended interventions for malaria in pregnancy or about
healthcare providers’ adherence to the WHO case manage-
ment guidelines. In this systematic review and meta-analysis
of qualitative, quantitative, and mixed methods studies, the
researchers explore the factors that affect women’s access to
treatment and healthcare provider practices for case
management of malaria during pregnancy. A systematic
review uses predefined criteria to identify all the research on
a given topic. Meta-analysis is a statistical method for
combining the results of several studies. A qualitative study
collects non-quantitative data such as reasons for refusing an
intervention, whereas a qualitative study collects numerical
data such as the proportion of a population receiving an
intervention.
What Did the Researchers Do and Find? The researchers
identified 37 studies (mostly conducted in Africa) that
provided data on the range of healthcare providers visited,
antimalarials used, and the factors influencing the choice of
healthcare provider and medicines among pregnant women
seeking treatment for malaria and/or the type and quality of
diagnostic and case management services offered to them
by healthcare providers. The researchers explored the data in
these studies using narrative synthesis (which summarizes
the results from several qualitative studies) and content
analysis (which identifies key themes within texts). Among
the studies that provided relevant data, one-quarter to three-
quarters of women reported malaria episodes during
pregnancy. More than 85% of the women who reported a
malaria episode during pregnancy sought some form of
treatment. Barriers to access to WHO-recommended treat-
ment among women included poor knowledge about drug
safety, and the use of self-treatment practices such as taking
herbal remedies. Factors that affected the treatment-seeking
behavior of pregnant women (‘‘determinants’’) included
prior use of antenatal care, education, and previous
experience of a miscarriage. Among healthcare providers,
reliance on clinical diagnosis of malaria was consistently
reported, as was poor adherence to the treatment policy.
Specifically, 28% and 72% of healthcare providers followed
the treatment guidelines for malaria during the first and
second/third trimesters of pregnancy, respectively. Finally,
the researchers report that concerns over side effects and
drug safety, patient preference, drug availability, and cost
drove the prescribing practices of the healthcare providers,
and that the determinants of provider practices included the
type (cadre) of heathcare worker, access to training, and
whether they were based in a public or private facility.
What Do These Findings Mean? These findings reveal
important limitations in the implementation of the WHO
policy on the treatment of malaria in pregnancy across many
parts of Africa and in several other malaria endemic regions.
Notably, they show that women do not uniformly seek care
within the formal healthcare system and suggest that, when
they do seek care, they may not be given the appropriate
treatment because healthcare providers frequently fail to
adhere to the WHO diagnostic and treatment guidelines.
Although limited by the sparseness of data and by
inconsistencies in study methodologies, these findings
nevertheless highlight the need for further systematic
assessments of the extent of substandard case management
of malaria in pregnancy in malaria endemic countries, and
the need to develop interventions to improve access to and
delivery of quality case management of malaria among
pregnant women.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001688.
N Information is available from the World Health Organiza-
tion on malaria (in several languages) and on malaria in
pregnancy; the 2010 Guidelines for the Treatment of
Malaria are available; the World Malaria Report 2013
provides details of the current global malaria situation
N The US Centers for Disease Control and Prevention also
provides information on malaria; a personal story about
malaria in pregnancy is available
N Information is available from the Roll Back Malaria
Partnership on all aspects of global malaria control,
including information on malaria in pregnancy
N The Malaria in Pregnancy Consortium is undertaking
research into the prevention and treatment of malaria in
pregnancy and provides links to the consortium’s
publications and an online library on malaria in pregnancy
N MedlinePlus provides links to additional information on
malaria (in English and Spanish)
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